|
Napísal užívateľ Administrator
|
|
Utorok, 17 August 2010 10:06 |
|
Záplavy v Regionálnom úrade WHO pre Európu
V sobotu večer (14. augusta 2010) zasiahli Kodaň silné zrážky, ktoré spôsobili záplavy po celej severo - východnej časti mesta, v oblasti, kde sa EURO/WHO nachádza.
Všetky budovy sú zaplavené v suterénoch alebo na úrovni prízemia. Voda spôsobila poškodenie energetického systému. Vypadnuté sú všetky telefónne linky v EURO/WHO a taktiež všetky počítačové servery. To ovplyvňuje prístup ku všetkým e-mailovým adresám nielen priamo v EURO/WHO, ale aj v niektorých kanceláriách WHO v jednotlivých krajinách. Akákoľvek e-mailová korešpondencia zaslaná na adresy zamestnancov Kancelárie WHO na Slovensku môže byť v tomto období stratená.
Dovoľujeme si Vás požiadať o zasielanie e-mailov určených Kancelárii WHO na Slovensku na adresu:
Táto emailová adresa je chránená pred spambotmi, aby ste ju videli, povolte JavaScript
Okrem toho nás môžete kontaktovať na telefónnych číslach:
tel./fax: 02/54 773 662
tel.: 02/59 373 140
Rokovania v EURO/WHO v Kodani
Stretnutia, ktoré sa mali uskutočniť v Kodani od 16.augusta do 28. augusta sú preložené. Kontaktujte p. Galinu Kærne na +45 51 54 40 44
Kancelária WHO na Slovensku
|
|
Napísal užívateľ Administrator
|
|
Nedeľa, 25 Júl 2010 07:33 |
Školenie v hodnotení zdravotníckych technológií
HEALTH TECHNOLOGY ASSESSMENT: FROM THEORY TO EVIDENCE TO POLICY WORKSHOP & FORUM
OCTOBER 19-22, TORONTO, CANADA
Course Objectives
By the end of the course, participants will:
- understand the concepts, methods and critical issues in the design and conduct of HTA;
- understand the different components of HTA and how to address them;
- understand the critical role of evidence and economic evaluation methods in the HTA process;
- be familiarized with introduction and advanced methods of economic evaluation through practical hands-on computer-based exercises; and
- appreciate different perspectives on HTA to complete the theory to evidence to policy loop.
For more information: http://www.path-hta.ca/Workshops/Health-Technology-Assessment-Workshop.aspx
|
|
Napísal užívateľ who
|
|
Piatok, 16 Júl 2010 07:49 |
World Health Summit 2010
October 10th - 13th, 2010, Berlin, Germany
Home
+++ First Call on The World Health Summit and Pfizer Award for Innovation in Biomedical Research endowed with Euro 75,000. Application deadline is July 31st, 2010. Please click here for details. +++
Program
Find the Preliminray Program in the 2nd Announcement that is available in the Download Section.
Focus Topics 2010
Translation
Delivering innovation beyond bench and bedside
Translating medical knowledge into interventions that benefit of patients across global regions remains one of the greatest challenges of modern medicine. It also requires innovative methods of accessing and transferring knowledge. What conditions make it possible to effectively translate knowledge into medical and public health interventions, and vice versa? How can we facilitate close links between research and clinical practice, and what innovative options exist? How can we improve exchange between scientists and policymakers, and how can research results have a greater impact on the political agenda? How can research capabilities be built up in poor countries in ways that are adapted to specific regional and cultural needs?
Transition
Coping with new health challenges and accelerating change
Our environment is constantly changing: non-communicable diseases play a growing role in developing countries; populations are aging; socio-demographic
developments also mean more and more people living in “megacities”; the health-related consequences of climate change are increasing; the worldwide financial crisis is affecting healthcare; the need for basic care in low- and middle-income countries is accelerating; and the focus of healthcare treatment is shifting from acute to chronic diseases. These are just a few of the profound changes forcing everyone in the health professions to constantly adapt the ways they develop and deliver health care interventions.
Transformation
Reinventing health management
To adequately respond to the constant changes occurring both within and beyond the healthcare field, health professionals, scientists, and political leaders must actively transform the ways we address health issues and deliver health care. In order to solve the global translation and transition challenges we face, requires us to rethink our approach to health management. What areas of cohesion and conflict exist between political and economic health agendas, and how can we develop models for cross-sector collaboration? How can we support a shift in focus from "sick care" to healthcare – in other words, from a model focused on treating specific diseases to an approach that truly
promotes health? How can global organizations foster the internationalization of healthcare? And how can we best fulfill our responsibilities to shape and execute the healthcare agenda? In order to make effective deci- sions on global health issues, we need adequate ways to measure outcomes of healthcare interventions on a global scale. |
|
Naposledý zmenené |
|
Napísal užívateľ who
|
|
Pondelok, 31 Máj 2010 00:00 |
Farmakoekonomika na Slovensku XIX
V. Slovenská a Česká farmakoekonomická konferencia
LIEKOVÁ POLITIKA, KVALITA ŽIVOTA, FARMAKOEKONOMIKA V PRAXI
Odborná konferencia s medzinárodnou účasťou
Kongresová sála MZ SR, Bratislava 17. júna 2010
Program
Výber prednášok
- Kvalita života a její postavení v ekonomice zdraví Tomáš Doležal, IHETA,ČR
- Kvalita života a jej postavenie v medicíne Iveta Rajničová-Nagyová, LF UPJŠ, Košice, SR
- Kvalita života ako indikátor kvality zdravotnej starostlivosti? Martin Višňanský, VšZP, a.s., SR
- Kvalita života v onkológii Petr Hájek, Pfizer, ČR
- Kvalita života v gastroenterológii Milan Hlista, Ján Bielik, FN Trenčín, FZ TnUAD, SR
- Uplatnenie fenoménu kvality života v systéme zdravotnej starostlivosti v SR Adam Hochel, MZ SR
- Lieková politika na Slovensku v období 2006 až 2010 Adam Hlôška, MZ SR
- Lieková politika v Čechách v období 2006 až 2010 Jan Švihovec, Tomáš Doležal, ČFES, ČR
- Výzvy pre rozvoj liekovej politiky na Slovensku Dominik Tomek, SSFE,SR
- Výzvy pre rozvoj liekovej politiky v Čechách Jan Švihovec, Tomáš Doležal, ČFES, ČR
- Postavenie ŠÚKL-u v liekovej politike na Slovensku Ján Mazag, ŠÚKL, SR
- Postavenie SÚKL-u v liekovej politike v Čechách Martin Beneš, SÚKL, ČR
- Utilizácia liekov na Slovensku v r. 2009 Viliam, Foltán, ssfeSR
- Utilizácia liekov v Čechách v r. 2009 Michal Prokeš, Infopharm, a.s., ČR
- Diskuse o referenčních skupinách Aleš Kmínek, AstraZeneca, ČR
- Vyplatí se bonifikace oproti neselektivním nesteroidním antiflogistikům? Michal Prokeš, Infopharm, a.s., ČR,
- Slovenská agentúra pre hodnotenie zdravotníckych technológií Dominik Tomek, SLOVAHTA, n.o.,SR
- Brachyterapia karcinómu prostatyz pohľadu farmakoekonomiky Viera Lesáková, SR
- Slovenská spoločnosť pre farmakoekonomiku v r. 2009 Ján Bielik, SSFE, SR
|
|
Naposledý zmenené |
|
|